MANUFACTURERS LIFE INSURANCE COMPANY, THE
InsurancePosition in AUPH — Aurinia Pharmaceuticals Inc.
CIK 928047
TORONTO, A6
Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$492,978
+$17,405 QoQ
Shares Held
29,050
-9.5% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#132
of 279 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MANUFACTURERS LIFE INSURANCE COMPANY, THE holds $1,655,634,902 across 242 Biotechnology names. AUPH ranks #145 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
554,085 | $275,230,642 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
893,795 | $269,059,108 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,955,733 | $145,662,993 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
539,037 | $129,891,745 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
2,988,121 | $105,749,602 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
147,961 | $92,259,601 | |
| 7 | RPRX |
Royalty Pharma plc
|
678,768 | $38,058,521 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
441,957 | $36,050,432 |
All Filings in AUPH
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $492,978 | 29,050 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $475,573 | 32,090 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $571,424 | 35,826 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $419,413 | 37,956 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $341,950 | 40,372 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $368,159 | 45,791 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $417,121 | 46,450 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $348,541 | 47,550 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $301,185 | 52,747 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $240,174 | 47,939 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $445,760 | 49,584 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $392,439 | 50,507 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $488,607 | 50,476 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $542,103 | 49,462 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $213,675 | 49,462 | Shares | Defined | 2023-08-11 | |
| 2022-09-30 | $373,969 | 49,730 | Shares | Defined | 2023-08-11 | |
| 2022-06-30 | $508,751 | 50,622 | Shares | Defined | 2023-08-11 | |
| 2021-06-30 | $1,423,591 | 109,845 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,488,223 | 114,611 | Shares | Defined | 2021-05-03 | |
| 2020-12-31 | $1,623,794 | 117,411 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,744,473 | 118,430 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $1,719,867 | 105,838 | Shares | Defined | 2020-08-10 | |
| No filing history on record for this holder in this stock. | ||||||